Evotec Share Price

0.62 (5.18%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 35,465
Bid Price 6.27
Ask Price 18.29
News -
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Evotec SE EVO NASDAQ Depository Receipt
  Price Change Change Percent Stock Price Last Traded
0.62 5.18% 12.60 16:30:00
Open Price Low Price High Price Close Price Prev Close
12.20 12.18 12.64 12.60 11.98
Trades Volume VWAP Dollar Volume Avg Volume
306 35,465  12.38  438,973 -
Last Trade Time Type Quantity Stock Price Currency
16:00:01 69  12.61 USD


Draw Mode:

Evotec SE Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
 4.46B 353.91M 353.91M  523.29M  136.94M 0.02 28.80
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
-  - - - -

more financials information »

News Evotec

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

EVO Historical

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.
1 Month0.
3 Months0.
6 Months0.
1 Year0.
3 Years0.
5 Years0.

Evotec SE is a drug discovery partnership company providing solutions to pharmaceutical & biotechnology companies, academic institutions as well as foundations, and not-for-profit organizations. The company offers its services in the area of neuronal diseases, diabetes & its complications, pain, inflammation, oncology, infectious diseases, respiratory & fibrosis, rare disease, and women's health. Its business segments are EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone drug discovery services on a typical fee-for-service basis or integrated drug discovery collaborations. The EVT Innovate segment develops drug discovery programs and assets, both internally or through academic collaborations. The majority of its revenue is derived from the EVT Execute segment.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.